ribocytokine il-2 bnt153
Generic: Ribocytokine IL-2 BNT153
ribocytokine il-2 bnt153: 1 clinical trial tracked.
ribocytokine il-2 bnt153 evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about ribocytokine il-2 bnt153, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trial Registry Records (1)
Phase I, First-in-human, Open-label, Dose Escalation Trial to Evaluate Safety, Pharmacokinetics, Pharmacodynamics, and Anti-tumor Activity of BNT152+153 in Patients With Solid Tumors
Primary endpoint: Occurrence of treatment-emergent adverse events (TEAEs) including Grade ≥ 3, serious, fatal TEAE by causal relationship to trial treatment
Interventionalopen86 enrolledStarted 2021-06Completion 2025-097 sites · Czechia, United StatesBioNTech SE